Online citations, reference lists, and bibliographies.
← Back to Search

Prognosis And Prognostic Factors Of Patients With Mesothelioma: A Population-based Study

S. van der Bij, H. Koffijberg, J. Burgers, P. Baas, M. J. van de Vijver, B. D. de Mol, K. Moons
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Background:It is important to regularly update survival estimates of patients with malignant mesothelioma as prognosis may vary according to epidemiologic factors and diagnostic and therapeutic management.Methods:We assessed overall (baseline) survival as well as related prognostic variables in a large cohort of 1353 patients with a confirmed diagnosis of malignant mesothelioma between 2005 and 2008.Results:About 50% of the patients were 70 years or older at diagnosis and the median latency time since start of asbestos exposure was 49 years. One year after diagnosis, 47% of the patients were alive, 20% after 2 years and 15% after 3 years. Prognostic variables independently associated with worse survival were: older age (HR=1.04 per year 95% CI (1.03–1.06)), sarcomatoid subtype (HR=2.45 95% CI (2.06–2.90)) and non-pleural localisation (HR=1.67 95% CI (1.26–2.22)).Conclusion:Survival of patients with malignant mesothelioma is still limited and depends highly on patient age, mesothelioma subtype and localisation. In addition, a substantial part of the patients had a long latency time between asbestos exposure and diagnosis.
This paper references
Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
S. J. Rao (2003)
Review: a gentle introduction to imputation of missing values.
A. Donders (2006)
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems
J. Edwards (2000)
Prognostic factors in malignant mesothelioma.
J. Burgers (2004)
A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters
A. Nowak (2010)
Prognostic factors and survival in malignant pleural mesothelioma.
T. van Gelder (1994)
Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma
Guntulu Ak (2009)
Asbestos Burden Predicts Survival in Pleural Mesothelioma
B. Christensen (2008)
Survival of peritoneal malignant mesothelioma in Italy: A population‐based study
D. Mirabelli (2009)
Occupational asbestos exposure: how to deal with suspected mesothelioma cases--the Dutch approach.
P. Baas (2006)
Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population-based study.
M. Janssen-Heijnen (1999)
Survival patterns for malignant mesothelioma: The seer experience
R. Spirtas (1988)
Population based epidemiology and prognosis of mesothelioma in Leeds, UK
A. Chapman (2008)
Mesothelioma: a review.
F. Mott (2012)
Malignant peritoneal mesothelioma: a multicenter study on 81 cases.
V. Manzini (2010)
Prognosis and prognostic research: Developing a prognostic model
P. Royston (2009)
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)

This paper is referenced by
Oncogenes and Tumor Suppressors Nonampli fi ed FGFR 1 Is a Growth Driver in Malignant Pleural Mesothelioma
L. Marek (2014)
Standardizing of Mesothelioma and Pseudomyxoma Care
Ranyell Spencer Sobreira Batista (2019)
Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study.
S. Francisci (2015)
Stratification of Malignant Pleural Mesothelioma Prognosis Using Recursive Partitioning Analysis
H. Suzuki (2013)
Malignant pleural mesothelioma : recognising an unmet need
Samal Gunatilake (2018)
Malignant Pleural Mesothelioma in Young People
Ahmed El Bastawisy (2017)
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
C. Menges (2014)
Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database
M. Zhuo (2019)
Simian virus 40 may be associated with developing malignant pleural mesothelioma
T. D. Thanh (2016)
Investigating heterogeneity of growth and drug response in mesotheliomas
Roxanne Otadoy (2013)
c-Met Axis − miR-34 a − Mesotheliomas with Enriched Cancer Stem Cells via a p 53 Tumor Suppressor Alterations Cooperate to Drive Aggressive
Craig W. Menges (2014)
Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report
J. Hu (2020)
Clinical significance of serum CA125 in diffuse malignant mesothelioma
X. Cheng (2016)
Connective tissue growth factor and β‐catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma
L. Jiang (2014)
Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma
L. Marek (2014)
A Nomogram to Predict Prognosis in Malignant Pleural Mesothelioma
S. Wang (2017)
Prognostic factors for malignant pleural mesothelioma
F. Brims (2013)
Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis
C. Chouaid (2018)
A Phase II Study of PF‐03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207
P. Wheatley-Price (2016)
Mesothelioma Micronodular Metastasis Pattern Confirmed by Transbronchial Cryobiopsy: Case Report.
Jordy W Kerkhoff (2020)
Downregulation of miR-99 a / let-7 c / miR-125 b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
A. Truini (2017)
MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma
Kyubo Kim (2020)
Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival
P. Zarogoulidis (2012)
Stratification of Malignant Pleural Mesothelioma Prognosis Using
Hidekazu SuzukiKazuhiro (2014)
Malignant Peritoneal Mesothelioma Mimicking Recurrent Diverticulitis
Ernesto S Robalino Gonzaga (2019)
A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis
F. Brims (2016)
Asbestos and Toxicological Concerns
Gregory A. Cade (2019)
Expected number of asbestos-related lung cancers in the Netherlands in the next two decades: a comparison of methods
S. van der Bij (2016)
Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
J. Andrici (2015)
Sarcomatoid Mesothelioma: Future Advances in Diagnosis, Biomolecular Assessment, and Therapeutic Options in a Poor-Outcome Disease
D. Galetta (2016)
Consensus Report of the 2015 Weinman International Conference on Mesothelioma
M. Carbone (2016)
Simultaneous acute myeloid leukemia and mesothelioma diagnoses in a long-term survivor of the 1984 Bhopal gas leak
J. Law (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar